Acute and Long-Term Immune-Treatment Strategies in Anti-LGI1 Antibody–Mediated Encephalitis

This study provides Class IV evidence that for patients with anti-LGI1 Ab-mediated encephalitis, rituximab prevents relapses and acute methylprednisolone is associated with favorable outcomes at 12 months.

Authors

Institutions

Publication Details

Journal
Neurology Neuroimmunology & Neuroinflammation
Published
2025-06-19
DOI
https://doi.org/10.1212/nxi.0000000000200412
Citations
4
Primary Topic
Autoimmune Neurological Disorders and Treatments
Type
article
Field-Weighted Citation Impact
5.56
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Acute and Long-Term Immune-Treatment Strategies in Anti-LGI1 Antibody–Mediated Encephalitis

Catherine Meade, Richard Macdonell, Charles Benjamin Malpas, James Broadley et al.
4 citations
Neurology Neuroimmunology & Neuroinflammation
Autoimmune Neurological Disorders and Treatments
5.56
article

Acute and Long-Term Immune-Treatment Strategies in Anti-LGI1 Antibody–Mediated Encephalitis

Catherine Meade, Richard Macdonell, Charles Benjamin Malpas, James Broadley, Andrew Duncan, Terence John O'Brien, Laurie McLaughlin, Jayashri Kulkarni, Udaya Seneviratne, Robb Wesselingh, James Beharry, Tomáš Kalinčík, Katherine Buzzard, Helmut Butzkueven, Ernest Butler, Liora ter Horst, Mastura Monif, Amy G. Brodtmann, Christina Kazzi, David Gillis, Fielding Joanne, Anneke van der Walt, Nabil Seery, Genevieve Skinner, Cassie Nesbitt, Tracie Tan, Stefan Blum, Andrew Swayne, Simon Broadley, Sarah Griffith, Meaghan Clough, Joshua Yap, Marie O’Shea, Bruce Taylor, Noushin Chini Foroush, Todd A. Hardy, Mirasol Forcadela, Wendyl D’Souza, Amy J. Halliday, Hannah Ford, David M. Tarlinton, Paul G. Sanfilippo, Sudarshini Ramanathan, Stephen Reddel, Rubina Alpitsis, Paul Beech, Nicola Warren, Tiffany Rushen, Yong Wang, Meng Tan, Brian Long, Yang Tran, Richard Wong, J.Philip MacIntyre, Alison Craig, Wen Wen Zhang, Fong Cheng Yi, Kevin Ko, Chris Kindt, Miri Forcadel
article en
4 citations

Abstract

This study provides Class IV evidence that for patients with anti-LGI1 Ab-mediated encephalitis, rituximab prevents relapses and acute methylprednisolone is associated with favorable outcomes at 12 months.

Neurology Neuroimmunology & NeuroinflammationVol. 12(4)
The University of Sydney (AU), The University of Queensland (AU), The University of Melbourne (AU), Geelong Hospital (AU), Concord Repatriation General Hospital (AU), Princess Alexandra Hospital (AU), Royal Hobart Hospital (AU), St Vincent's Hospital Melbourne (AU), Eastern Health (AU), Peninsula Health (AU), Monash Health (AU), Melbourne Health (AU), Alfred Health (AU), Austin Health (AU), Monash University (AU)
Good health and well-being
Openalex Percentile: Top 4%
Autoimmune Neurological Disorders and Treatments
5.56
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.